Investor mix
6 investors on record; lead investors include Nitto Boseki, REVIC.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Bank & private debt | 1 | 17% |
| Other / undisclosed | 3 | 50% |
Direct-to-consumer tests for intestinal microbiome profiling
6 investors on record; lead investors include Nitto Boseki, REVIC.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Bank & private debt | 1 | 17% |
| Other / undisclosed | 3 | 50% |